. Author manuscript; available in PMC: 2014 Nov 1.

Published in final edited form as: Breast Cancer Res Treat. 2013 Oct 19;142(2):10.1007/s10549-013-2725-5. doi: 10.1007/s10549-013-2725-5

Table 3.

Characteristics of 104 screen-detected cancers diagnosed in patients with LCIS by screening group

Screen-detected tumors	All (n = 104)	MRI screening group (n = 61)	Conventional screening group (n = 43)	p value
Histology				0.10^**
DCIS	36 (35 %)	25 (41 %)	11 (26 %)
IDC	30 (28 %)	14 (21 %)	16 (37 %)
ILC	29 (28 %)	17 (28 %)	12 (28 %)
IDC with lobular features	6 (6 %)	4 (7 %)	2 (5 %)
Special types	3 (3 %)	1 (2 %)	2 (5 %)
Median tumor size^*	0.80 cm (0.1–3.5)	0.5 cm (0.1–3.5)	0.95 cm (0.1–2.7)	0.09
Node status				0.74
Positive	14 (22 %)	7 (21 %)	7 (24 %)
Negative	49 (78 %)	27 (79 %)	22 (76 %)
Not available	5	2	3
IHC profile				0.53
ER+ HER2−	55 (89 %)	28 (88 %)	27 (90 %)
ER+ HER2+	4 (6 %)	3 (9 %)	1 (3 %)
ER− HER2+	3 (5 %)	1 (3 %)	2 (7 %)
Not available		4	2

DCIS ductal carcinoma in situ, IDC infiltrating ductal carcinoma, ILC infiltrating lobular carcinoma, ER estrogen receptor, PR progesterone receptor

For 63/68 invasive cancers with complete size information

^**

DCIS versus invasive histology